Table 2 |
|
|
Threshold for probability of BRCA1/BRCA2 mutation |
|
|
Chance that a mutation is present* |
Clinical criteria |
|
|
|
|
<10% |
All single cases of breast or ovarian cancer |
|
10% |
Single breast cancer cases aged <35 years |
|
>10-≤ 30% |
Two breast cancer cases aged <50 years |
|
One breast cancer case aged <40 years in an |
|
|
Ashkenazi jew |
|
|
≤ 50% |
Three breast cancer cases aged <50 years |
|
Four to five breast cancer cases, no ovarian cancer |
|
|
One breast and ovarian cancer case |
|
|
>50% |
More than one breast and ovarian cancer case |
|
At least four cases of female/male breast cancer |
|
|
More than six female breast cancer cases |
|
|
|
|
|
*The chance of detecting a mutation is lower, because at least 15% of mutations are regulatory (ie they are not in the coding region of the gene that is the area tested), and the genetic screening methods are approximately 80% sensitive if sequencing is not used. Cases refer to first-degree relatives or first/second-degree relatives if multiple cases. Data from [7**,16,19,21,23,25,72]. |
|
|
Eeles Breast Cancer Res 2000 2:283 doi:10.1186/bcr70 |
|